Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

IMS 2023 | The prognostic and potentially therapeutic value of liquid biopsy in multiple myeloma

Nicholas Bingham, MBBS, FRACP, FRCPA, Alfred Health & Monash University, Melbourne, Australia, discusses the prognostic and therapeutic value of liquid biopsy in multiple myeloma, and further highlights how this approach may be used to highlight mutations in cell-free DNA (cfDNA) and better predict patient response to therapy. This interview took place at the 20th International Myeloma Society (IMS) Annual Meeting, held in Athens, Greece.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.


Celgene/BMS – travel support
Janssen – honorarium